Google’s AlphaGenome 2 zooms in on the cellular roots of disease
TL;DR
A graphic representing Google’s AlphaGenome Atlas. | Image: Google Researchers at Google DeepMind have unveiled a new AI model designed to unravel how changes in our DNA affect different cells, giving scientists a more detailed view of a notoriously difficult problem that could hold important clues to the causes of disease - and point the way to new treatments. AlphaGenome 2 is the successor to DeepMind's genome-predicting AI model AlphaGenome, which was released last year.
Nauti's Take
Before treating AlphaGenome 2 as a building block for biomedical workflows, small teams should verify three points: which cell types and diseases it actually covers, how reproducible its predictions are, and which data or models will be available. The current story is based on a single Verge summary, so the practical value remains unverified until primary results, benchmarks, and usage details are published.
Sources